Gerresheimer (GRRMF) News Today $69.75 -9.10 (-11.54%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period SQ Innovation's Lasix ONYU With Gerresheimer On-body Drug Delivery Device Gets FDA ApprovalDecember 16, 2024 | markets.businessinsider.comBernstein Sticks to Its Buy Rating for Gerresheimer (0NTI)December 14, 2024 | markets.businessinsider.comEQS-News: Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma GroupDecember 11, 2024 | markets.businessinsider.comJ.P. Morgan Remains a Buy on Gerresheimer (0NTI)December 6, 2024 | markets.businessinsider.comUBS Reaffirms Their Buy Rating on Gerresheimer (0NTI)November 30, 2024 | markets.businessinsider.comBernstein Remains a Buy on Gerresheimer (0NTI)November 26, 2024 | markets.businessinsider.comGerresheimer AG (ETR:GXI) is a favorite amongst institutional investors who own 70%November 25, 2024 | uk.finance.yahoo.comGerresheimer (0NTI) Gets a Buy from Kepler CapitalOctober 17, 2024 | markets.businessinsider.comJ.P. Morgan Reaffirms Their Buy Rating on Gerresheimer (0NTI)October 11, 2024 | markets.businessinsider.comGerresheimer shares jump as activist investor buys over 5% stakeOctober 9, 2024 | reuters.comGerresheimer (0NTI) Receives a Buy from Kepler CapitalOctober 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Gerresheimer Despite Short-Term Challenges: A Long-Term Growth PerspectiveOctober 1, 2024 | markets.businessinsider.comGerresheimer-Aktienausblick aufgrund von Verzögerungen bei der Markterholung und Produktionsstopp gesenktOctober 1, 2024 | de.investing.comEQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025September 30, 2024 | markets.businessinsider.comGerresheimer Lowers FY24 OutlookSeptember 30, 2024 | markets.businessinsider.comGerresheimer (0NTI) Gets a Buy from J.P. MorganSeptember 21, 2024 | markets.businessinsider.comGerresheimer AG (GXI.F)September 18, 2024 | sg.finance.yahoo.comDeutsche Bank Remains a Buy on Gerresheimer (0NTI)September 16, 2024 | markets.businessinsider.comGerresheimer AG (GXI.HA)August 22, 2024 | uk.finance.yahoo.comGerresheimer Announces Expansion Of Manufacturing Capabilities In Peachtree CityMay 27, 2024 | markets.businessinsider.comEQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass businessMay 23, 2024 | markets.businessinsider.comGerresheimer stock jumps on news it will acquire Blitz LuxCoMay 23, 2024 | za.investing.comGerresheimer In Deal With RxCap To Offer Connected Adherence Solutions; Buys Minority StakeApril 29, 2024 | markets.businessinsider.comGerresheimer grows Q1 organic revenue by 2.8%April 11, 2024 | msn.comEQS-News: Gerresheimer makes solid start to the financial year 2024April 11, 2024 | markets.businessinsider.comGerresheimer supplies 'key players' in GLP-1 drugs market, CEO saysApril 11, 2024 | reuters.comGerresheimer expects sales boost from burgeoning obesity drugs sectorApril 11, 2024 | reuters.comGerresheimer Q1 Profit Edges Down, Adj. EBITDA Up; Backs FY24 View, Sees Growth AheadApril 11, 2024 | markets.businessinsider.comInternational Companies Drive Diabesity InnovationMarch 29, 2024 | seekingalpha.comWeight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO saysMarch 29, 2024 | reuters.comGerresheimer price target raised by EUR 5 at BarclaysFebruary 26, 2024 | realmoney.thestreet.comJEFFERIES stuft GERRESHEIMER AG auf 'Buy'JEFFERIES stuft GERRESHEIMER AG auf 'Buy'February 22, 2024 | finanznachrichten.deAktien»Nachrichten»GERRESHEIMER AKTIE»Gerresheimer Q4 Adj. Profit RisesFebruary 22, 2024 | finanznachrichten.deEQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapyJanuary 4, 2024 | markets.businessinsider.comGerresheimer To Collaborate With Aptar Digital To Develop Integrated Solution For Cancer TherapyJanuary 4, 2024 | markets.businessinsider.comGerresheimer Signs Long-term Electricity Supply Deal With PNE AGNovember 28, 2023 | markets.businessinsider.comEQS-News: Gerresheimer AG: Gerresheimer on track to another strong financial yearOctober 5, 2023 | markets.businessinsider.comGerresheimer Q3 Adj. Net Income Declines, Revenues Up 5.5% Organic; Confirms FY GuidanceOctober 5, 2023 | nasdaq.comGerresheimer AG: Gerresheimer Continues Dynamic Growth in First Half of 2023July 6, 2023 | benzinga.comEQS-News: Gerresheimer AG: Gerresheimer continues dynamic growth in first half of 2023July 6, 2023 | markets.businessinsider.comGerresheimer says revenue rose 16.6% in H1July 6, 2023 | msn.comGerresheimer H1 Adj. EBITDA Up 23.0% Organically, Revenues Up 16.6%; Confirms GuidanceJuly 6, 2023 | markets.businessinsider.comEurope Pharmaceutical Packaging Market Report 2023: Featuring Amcor, Aptar Group, Berry Global, Laser Gerresheimer and WestRockApril 27, 2023 | finance.yahoo.comGerresheimer AG Q4 adjusted EBITDA up Y/YFebruary 23, 2023 | msn.comGerresheimer AG Increases Its Revenue, Adj. EBITDA Guidance - Quick FactsDecember 6, 2022 | markets.businessinsider.comEQS-DD: Gerresheimer AG englishOctober 13, 2022 | markets.businessinsider.comGerresheimer AG (GRRMF) Q3 2022 Earnings Call TranscriptOctober 12, 2022 | seekingalpha.comEQS-News: Gerresheimer AG: Gerresheimer reports double digit growth in revenue and earnings for the third quarterOctober 12, 2022 | markets.businessinsider.comGerresheimer Q3 Profit Rises, Reaffirms FY22 Outlook; Sees Growth In Mid TermOctober 12, 2022 | nasdaq.comEQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statementsOctober 5, 2022 | markets.businessinsider.com Get Gerresheimer News Delivered to You Automatically Sign up to receive the latest news and ratings for GRRMF and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol GRRMF Media Mentions By Week GRRMF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRRMF News Sentiment▼0.000.60▲Average Medical News Sentiment GRRMF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRRMF Articles This Week▼20▲GRRMF Articles Average Week Get Gerresheimer News Delivered to You Automatically Sign up to receive the latest news and ratings for GRRMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ANSLY News Today ANSLF News Today CZMWY News Today CLPBF News Today CNVVY News Today FSPKF News Today INND News Today LUCYW News Today NNCSF News Today OLYMY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GRRMF) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gerresheimer AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Gerresheimer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.